Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats.
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats.
复制标题
DOI:
10.1136/svn-2022-001907
复制
发表时间:
2023-06
影响因子:
5.9
通讯作者:
Chen, Gang
中科院分区:
文献类型:
--
作者:
Zhang, Jie;Li, Haiying;Xu, Zhongmou;Lu, Jinxin;Cao, Chang;Shen, Haitao;Li, Xiang;You, Wanchun;Chen, Gang
Sex differences affect the occurrence, progression and regression of subarachnoid haemorrhage (SAH). Oestrogen plays a protective role in alleviating the vasospasm and neuronal apoptosis induced by SAH. However, whether oestrogen affects blood‒brain barrier (BBB) integrity has not been fully studied. Oestrogen has been found to regulate the sonic hedgehog (SHH) signalling pathway through the oestrogen receptor in gastric cancer and adrenal glands, and the SHH signalling pathway has an important role in maintaining the BBB by upregulating the expression of tight junction proteins. In this study, we investigated the relationship between oestrogen and the SHH signalling pathway using clinical data and established an experimental SAH model to explore whether oestrogen could ameliorate BBB damage after SAH through the SHH pathway. Correlations between oestrogen and the SHH pathway were analysed by patients’ cerebrospinal fluid (CSF) samples and the Genotype-Tissue Expression database (GTEx). Then, an experimental rat SAH model was established using the endovascular perforation method and treated with oestrogen, oestrogen inhibitors and SHH signalling pathway inhibitors. Then, the effects of oestrogen on BBB damage were analysed by western blot, immunofluorescence and neurobehavioural experiments. ESLIA detection and correlation analysis showed that oestrogen levels in patients’ CSF were positively correlated with the SHH pathway, which was further verified by GTEx gene-correlation analysis. SHH was found to be mainly expressed in neurons and astrocytes in rats under physiological conditions and was upregulated by oestrogen pretreatment. In the SAH model, oestrogen pretreatment was found to reverse SAH-induced decreases in the SHH pathway, which were counteracted by oestrogen receptor inhibitors. Furthermore, oestrogen pretreatment reduced SAH-induced BBB damage, brain oedema and neurological dysfunction, which were eliminated by SHH pathway inhibitors. In conclusion, we demonstrate here that oestrogen pretreatment ameliorates brain injury after SAH, at least in part through SHH pathway-mediated BBB protection.
登录
查看更多内容
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
11.1
作者:
Fang Y;Wang X;Lu J;Shi H;Huang L;Shao A;Zhang A;Liu Y;Ren R;Lenahan C;Tang J;Zhang J;Zhang JH;Chen S
通讯作者:
Chen S
影响因子:
1.9
作者:
Yuan S;Liu KJ;Qi Z
通讯作者:
Qi Z
影响因子:
2.9
作者:
O'Connor, CA;Cernak, I;Vink, R
通讯作者:
Vink, R
影响因子:
11
作者:
de Rooij, N. K.;Linn, F. H. H.;Rinkel, G. J. E.
通讯作者:
Rinkel, G. J. E.